Clinical Trial Update: Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the safety, immunogenicity and efficacy of the R21/Matrix-M1 malaria vaccine in healthy women of childbearing potential in Mali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• R21/Matrix-M1 Malaria Vaccine (R21/Matrix-M1 malaria vaccine)

Snippet

Sponsor: University of Oxford | Conditions: Healthy Women of Child Bearing Potential | Phase 2 | Status: ACTIVE_NOT_RECRUITING